The Need of Pharmacovigilance Activities in Yemen

Mohammed Ahmed Alshakka  Abdulkareem Mohammed Alsh

Authors

Mohammed Ahmed Alshakka Abdulkareem Mohammed Alsh

Keywords:

adverse drug reaction, drug safety, pharm-acovigilance, safety monitoring, yemen

Abstract

Adverse drug reactions, medication errors and other drug-related problems are the leading causes of hospital-lisation and are associated with a huge economic burden and significant human suffering. This serious issue of medication therapy also contributes to morbidity and mortality. At present, the monitoring of adverse drug reactions was started in Yemen by establishing a pharmacovigilance centre in 2011. Till now there is no published information about its work , number of reports and how they process it. The country and public are facing with many safety problems related to drug smuggling, counterfeit drugs, improper and irrational use of drugs, importation of unnecessary drugs and medical errors. Therefore, it is necessary to make serious steps and active regulations in Yemen to ensure patients and public safety in relation to medicines use.

Downloads

How to Cite

The Need of Pharmacovigilance Activities in Yemen. (2014). Global Journal of Medical Research, 14(B4), 9-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/575

Download Citation

References

(1972) Unknown Title.

P Pouyanne, F Haramburu, J Imbs, B Begaud (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. 320(7241), 1036-1036.

Jean-Blaise Wasserfallen, Françoise Livio, Thierry Buclin, Laurent Tillet, Bertrand Yersin, Jérôme Biollaz (2001) Rate, type, and cost of adverse drug reactions in emergency department admissions. 12(5), 442-447.

D Classen, S Pestotnik, R Evans, J Lloyd, J Burke (1997) Adverse drug events in hospitalised patients. Excess length of stay, extra costs, and attributable mortality. 277, 301-306.

Dong-Churl Suh, Betsy Woodall, Soung-Kook Shin, Evelyn R Hermes-De Santis (2000) Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients. 34(12), 1373-1379.

D Classen, S Pestotnik, R Evans (1997) Adverse drug events in hospitalized patients. 277(4), 301-306.

Jason Lazarou, Bruce Pomeranz, Paul Corey (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients. 279(15), 1200.

A Lee, Shl Thomas (2003) Roger Walker and Clive Edwards, Clinical Pharmacy and Therapeutics (3rd Edition) London: Churchill Livingstone, 2003. 55(12), 1709-1709.

S Pourseyed, F Fattahi, Z Pourpak, K Gholami, S Shariatpanahi, A Moin, A Kazemnejad, M Moin (2008) Adverse drug reactions in patients in an Iranian department of internal medicine.

Kheirollah Gholami, Gloria Shalviri (1999) Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions. 33(2), 236-240.

R Arulmani, S Rajendran, B Suresh (2008) Adverse drug reaction monitoring in a secondary care hospital in South India. 65(2), 210-216.

Al-Malaq Hm, Al-Aqeel Sa, Al-Sultan Ms (2008) Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh. (8), 1145-1150.

N Jha, O Bajracharya, T Namgyal (2007) Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. 5(4), 504-510.

S Olsson (2001) The need for pharmacovigilance In: Gupta SK. Pharmacology and therapeutics in the new millennium. 502-508.

(2002) Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database. 31(10), 885-960.

Yaseen Alqubati Shaher Medicine prices in yemen.

(2003) Country Cooperation Strategy for WHO and the Republic of 2002-2007.

(2008) Alshakka Mohammed Importance of Adverse Drug Reactions Monitoring in Yemen.

(1985) World Health Organization Publications - World Health Organization Expert Committee on Onchocerciasis 3rd Report. Technical Report Series No. 752. 167 pages. ISBN 92 4 120752 3. World Health Organization, Geneva, 1987. SF 24.. 96(3), 644-644.